We assessed the diagnostic performance of 18F-FDG PET in detecting paraaortic lymph node (PALN) metastasis in patients with cervical cancer. >Methods: Through a search of MEDLINE and EMBASE '/> Diagnostic Value of 18F-FDG PET for Evaluation of Paraaortic Nodal Metastasis in Patients with Cervical Carcinoma: A Metaanalysis
首页> 外文期刊>The Journal of Nuclear Medicine >Diagnostic Value of 18F-FDG PET for Evaluation of Paraaortic Nodal Metastasis in Patients with Cervical Carcinoma: A Metaanalysis
【24h】

Diagnostic Value of 18F-FDG PET for Evaluation of Paraaortic Nodal Metastasis in Patients with Cervical Carcinoma: A Metaanalysis

机译:18F-FDG PET对宫颈癌患者主动脉旁淋巴结转移的诊断价值:荟萃分析

获取原文
           

摘要

id="p-1">We assessed the diagnostic performance of 18F-FDG PET in detecting paraaortic lymph node (PALN) metastasis in patients with cervical cancer. >Methods: Through a search of MEDLINE and EMBASE (1980 to March 2009), we performed a random-effects metaanalysis. A summary receiver-operating-characteristic curve was constructed using hierarchical regression models. To identify other sources of heterogeneity, regression metaanalysis was performed. >Results: Patients (n = 385) from 10 studies were analyzed. Although specificity of 18F-FDG PET was consistent (97%; 95% confidence interval [CI], 93%a?’99%), sensitivity was low and heterogeneous among the studies (34%; 95% CI, 10%a?’72%). Although regression metaanalysis did not identify any source to which heterogeneity could be attributed, it revealed a trend of increasing sensitivity according to an increase in the prevalence of PALN metastasis (P = 0.001). In the 5 studies with prevalence greater than 15%, estimated sensitivity and specificity were 73% (95% CI, 53%a?’87%) and 93% (95% CI, 86%a?’97%), respectively. With the diagnostic performance, assuming the prevalence of 15%, the calculated false-positive and -negative rates were 35% and 5%, respectively. >Conclusion: In detecting PALN metastasis, PET performs acceptably only in populations with a relatively high probability of PALN metastasis. Otherwise, we found no evidence to justify the evaluation of PALN based solely on PET in cervical cancer.
机译:id =“ p-1”>我们评估了 18 F-FDG PET对子宫颈癌患者主动脉旁淋巴结转移的诊断性能。 >方法:通过搜索MEDLINE和EMBASE(1980年至2009年3月),我们进行了随机效应荟萃分析。使用分层回归模型构造了一条汇总的接收器操作特性曲线。为了确定异质性的其他来源,进行了回归荟萃分析。 >结果:分析了10项研究的患者( n = 385)。尽管 18 F-FDG PET的特异性是一致的(97%; 95%置信区间[CI],93%a?99%),但研究之间的敏感性低且异质性(34%; 97%; 99%; 99%)。 95%CI,10%a?'72%)。尽管回归荟萃分析未发现任何可归因于异质性的来源,但它揭示出随着PALN转移发生率的增加( P = 0.001),敏感性增加的趋势。在5个患病率大于15%的研究中,估计的敏感性和特异性分别为73%(95%CI,53%a?87%)和93%(95%CI,86%a?97%)。在诊断性能方面,假设患病率为15%,则计算出的假阳性率和阴性率分别为35%和5%。 >结论:在检测PALN转移时,PET仅在具有较高PALN转移可能性的人群中表现良好。否则,我们没有发现任何证据证明仅基于PET评估PALN在宫颈癌中是合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号